Transaction · 0001787306-25-000014

Burnett Patrick

Burnett Patrick, SR, reported an open-market or private sale at Arcutis Biotherapeutics, Inc. involving 12116.000000 shares for an estimated $153873.20. Reported holdings after the transaction were 114862.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SSR
ARQTArcutis Biotherapeutics, Inc.
Filing timeFeb 05
Trade dateFeb 03, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
Pre-filing
Returns since

ARQT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ARQT since 2025-02-05Filed 576 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001787306-25-000014
Common Stock
Transaction date
Feb 03, 2025
Filed Feb 05, 2025, 01:00 AM · 2d delay
Shares
12.1k sh
$1.27k per share
Estimated value
-$15.3M
Computed from shares × price
Holdings after
114k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligation in connection with the vesting of Restricted Stock Units ("RSUs"), granted on Janua…

  2. F2

    The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $12.545 to $13.0096, inclusive. The Reporting Person hereby undert…

  3. price within the range set forth in this footnote.

Original filing · 0001787306-25-000014
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ARQT